A postmortem study showed increases in EAAT1 levels in a subset of pyramidal neurons exhibiting degeneration in the AD brain (139), whereas another postmortem study and in vitro assay showed impaired function of EAAT2 in the AD brain (140). The gene discussed is SLC1A2; the disease is Alzheimer disease.